雖然我們體內的許多細胞可以積累致癌突變，但這些事件中的大多數不會導致腫瘤形成，因為這些異常細胞被防御機制消除。相反，當突變發生在對其特異性敏感的特定細胞類型中時

單細胞mRNA測序(scRNA-seq)允許分析異質細胞群，提供解決各種生物和醫學問題的令人興奮的可能性。最近開發了一系列方法，因此有必要系統地比較它們的靈敏度，準確度，精度和成本效

Single-cell mRNA sequencing (scRNA-seq) allows to profile heterogeneous cell populations, offering exciting possibilities to tackle a variety of biological and medical questions. A range of methods has been recently developed, making it nece

To treat and prevent pregnancy-related disorders, researchers must understand not only what can go wrong, but when. Complications, such as preeclampsia and pre-term birth, often occur in the second or third trimester, and most research to da

為了治療和預防與妊娠有關的疾病，研究人員不僅要了解可能出現的問題，還要了解何時出錯。并發癥如先兆子癇和早產，通常發生在妊娠中期或妊娠晚期，迄今為止的大多數研究都集

單細胞RNA-seq揭示了細胞群中固有的細胞異質性，這在許多臨床和研究應用中非常重要。

Single-cell RNA-seq reveals the cellular heterogeneity inherent in the population of cells, which is very important in many clinical and research applications. Recent advances in droplet microfluidics have achieved the automatic isolation, l

Drop-seq is a technology we developed to enable biologists to analyze RNA expression genome-wide in thousands of individual cells at once. We first described this in a 2015 paper in Cell. Though commercial implementations of droplet-